Release Date: 24/07/14 12:26 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 181.11KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%